Table 1.
Method/device, rest, and number of readings from BP protocols for prior large observational studies and clinical trials
| Study | Year | Type of Study | Method/Device | Wait/Rest, min | # Readings |
|---|---|---|---|---|---|
| Framingham23 | 1970s | Observational | Manual | 5 | 2 |
| SHEP24 | 1991 | Clinical trial | Manual | 5 | 2 |
| MDRD5 | 1994 | Clinical trial | Manual | 5 | 3 |
| UKPDS7 | 1998 | Clinical trial | Manual | 5 | 3 |
| ALLHAT8 | 2000 | Clinical trial | Manual | 5 | 2 |
| HOPE9,10 | 2001 | Clinical trial | Manual | 15 | 2 |
| HYVET25 | 2001 | Clinical trial | Manual and automated | 5 | 2 |
| AASK6 | 2002 | Clinical trial | Manual | 5 | 3 |
| ADVANCE11 | 2007 | Clinical trial | Automated/Omron | 5 | 2 |
| CRIC26 | 2009 | Observational study | Manual | 5 | 3 |
| ACCORD12 | 2010 | Clinical trial | Automated/Omron | 5 | 3 |
| SPS327 | 2011 | Clinical trial | Automated/Colin electronic device | 15 | 3 |
| ONTARGET13 | 2012 | Clinical trial | Automated/Omron | 3 | 2 |
| CKD-JAC28 | 2013 | Observational study | Manual | 5 | 3 |
SHEP, Systolic Hypertension in the Elderly Program; UKPDS, UK Prospective Diabetes Study; ALLHAT, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial; HOPE, Heart Outcomes Prevention Evaluation; HYVET, Hypertension in the Very Elderly Trial; ADVANCE, Action in Diabetes and Vascular disease: preterAx and diamicroN-MR Controlled Evaluation; CRIC, Chronic Renal Insufficiency Cohort; ACCORD, Action to Control Cardiovascular Risk in Diabetes; SPS3, Secondary Prevention of Small Subcortical Strokes; ONTARGET, Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial; CKD-JAC, Chronic Kidney Disease Japan Cohort.